T Cell News and Research

Latest T Cell News and Research

TRU-016 abstracts to be presented at ASH meeting

Emergent BioSolutions Inc. today announced the acceptance of four abstracts for presentation at the 52nd Annual Meeting of the American Society of Hematology to be held from December 4 to 7 in Orlando, Florida. The presentations include an oral presentation on the results of a Phase I dose escalation, monotherapy study of TRU-016 for patients with chronic lymphocytic leukemia.

10 Nov 2010

Long-term use of statins unlikely to substantially increase overall cancer risk: Study

Researchers have further established that long-term use of statins is unlikely to substantially increase or decrease overall cancer risk, according to study results presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held Nov. 7-10, 2010, in Philadelphia.

10 Nov 2010

Researchers study drug's ability to restore retinal health in eyes of diabetic patients

One drug's startling ability to restore retinal health in the eyes of diabetic mice has researchers wanting to learn more about how it works and whether it might do the same for people.

10 Nov 2010

Epratuzumab reduces SLE disease activity in phase IIB EMBLEM study

UCB and U.S. based partner Immunomedics Inc. announced that results from the phase IIB study, EMBLEM, showed that certain doses of epratuzumab were associated with a meaningful and statistically significant reduction in disease activity in adult patients with moderate to severe active SLE.

10 Nov 2010

Medicinal mushroom formula fights breast cancer

Researchers at Indiana University and Methodist Research Institute studied an innovative medicinal mushroom formula against breast cancer. The impressive results are found in the December issue of the International Journal of Oncology. Lead investigator Dr. Daniel Sliva says, "The formula inhibits growth of highly metastatic human breast cancer cells, and suppresses metastatic potential of these cells."

10 Nov 2010

18 partner consortium to develop lab-on-a-chip to detect brain diseases

A consortium of 18 partners embarks on the development of a lab-on-a-chip to detect Alzheimer´s disease and similar diseases in the brain. The project is funded by the EU´s 7th Framework programme for nanotechnology.

10 Nov 2010

UC Davis researchers identify new pathway to repair oxidative-damaged DNA

UC Davis researchers have found a new pathway for repairing DNA damaged by oxygen radicals. The results are published this week in the journal Proceedings of the National Academy of Sciences.

10 Nov 2010

Contraceptive, antiviral gel using bee venom wins 2010 Gates Foundation grant

A vaginal gel that affords both contraception and HIV protection using nanoparticles that carry bee venom is one of the bold, unconventional ideas that won a 2010 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation.

10 Nov 2010

mHealth Alliance annual summit kicks off with $1M HP donation, discussion of improving maternal, child health

The mHealth Alliance on Monday at its summit in Washington, D.C., "announced a two-year $1 million aggregate donation from HP" aimed at furthering the alliance's goal of delivering quality health care "at the furthest reaches of wireless networks and mobile devices," mobihealthnews reports.

10 Nov 2010

Using mild painkillers during pregnancy can increase risk of male reproductive disorders

New evidence has emerged that the use of mild painkillers such as paracetamol, aspirin and ibuprofen, may be part of the reason for the increase in male reproductive disorders in recent decades.

10 Nov 2010

Grand Challenges Explorations projects receive new grants for tuberculosis research

Weill Cornell Medical College announced today that it was awarded two $100,000 grants from the Bill & Melinda Gates Foundation as part of the next phase of Grand Challenges Explorations, an initiative to encourage bold and unconventional ideas for global health.

10 Nov 2010

Immunologix partners with Genscript to develop human antibody therapeutics

Immunologix, Inc, a Charleston, SC biotechnology company and a leader in fully human therapeutic antibodies for a variety of diseases and GenScript, a contract research organization (CRO) based in Piscataway, NJ and the industry leader in bio-reagent services, assay development & screening, lead optimization, and antibody drug development, announced today that the companies have formed a strategic partnership to offer a complete platform for producing human antibody therapeutics.

10 Nov 2010

Diamyd completes patient screening for DiaPrevent Phase III study

Diamyd Medical has completed the screening of patients for the US Phase III study, DiaPrevent, ending the recruitment campaign. More than 310 recently diagnosed type 1 diabetes patients between 10 and 20 years of age have already been enrolled in the study and have received their first injection of the antigen-based therapy Diamyd® or placebo.

10 Nov 2010

CRi adds TRIO to Nuance multispectral imaging product family

Cambridge Research & Instrumentation, Inc. (CRi), a leader in multicolor imaging solutions for preclinical and clinical research, today announced the newest addition to the award-winning Nuance™ multispectral imaging product family for multicolor tissue and cell-based imaging. The TRIO system is compact, multipurpose and affordable, offering a simplified interface and versatile design to fit any microscope with a camera-mount.

10 Nov 2010

Hypernetworking and hypertexting bad for kids in more ways than one: Study

According to a new study adolescents who text excessively or who are hooked on social networking sites are more likely to engage in unhealthy behaviors like smoking and binge drinking than their peers who are not similar users. Scientists at the Case Western Reserve School of Medicine surveyed 4,257 high school students from an urban county in the Midwest to look at the health effects of communications technology usage.

9 Nov 2010

ARIAD reports $20.4 million net loss for third quarter 2010

ARIAD Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2010 and provided an update on corporate developments.

9 Nov 2010

ArQule reduces third quarter net loss to $6,394,000

ArQule, Inc. today reported its results of operations for the fiscal quarter and nine months ended September 30, 2010.

9 Nov 2010

Semafore's SF1126 for B-cell chronic lymphocytic leukemia granted FDA orphan drug designation

Semafore Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's SF1126 product candidate for the treatment of B-cell chronic lymphocytic leukemia (CLL). In April 2010, the Company initiated an expansion of its ongoing Phase I clinical study into this disease setting. SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR).

9 Nov 2010

Human blood from adult human skin

In an important breakthrough, scientists at McMaster University have discovered how to make human blood from adult human skin.

9 Nov 2010

Excessive texting and networking raise new health concerns for teens

Texting while driving can be a deadly combination for teenagers. Yet, new data released today reveal that the dangers of excessive texting among teens are not limited to the road. Hyper-texting and hyper-networking are now giving rise to a new health risk category for this age group.

9 Nov 2010

T Cell News and Research

Latest T Cell News and Research

TRU-016 abstracts to be presented at ASH meeting

Long-term use of statins unlikely to substantially increase overall cancer risk: Study

Researchers study drug's ability to restore retinal health in eyes of diabetic patients

Epratuzumab reduces SLE disease activity in phase IIB EMBLEM study

Medicinal mushroom formula fights breast cancer

18 partner consortium to develop lab-on-a-chip to detect brain diseases

UC Davis researchers identify new pathway to repair oxidative-damaged DNA

Contraceptive, antiviral gel using bee venom wins 2010 Gates Foundation grant

mHealth Alliance annual summit kicks off with $1M HP donation, discussion of improving maternal, child health

Using mild painkillers during pregnancy can increase risk of male reproductive disorders

Grand Challenges Explorations projects receive new grants for tuberculosis research

Immunologix partners with Genscript to develop human antibody therapeutics

Diamyd completes patient screening for DiaPrevent Phase III study

CRi adds TRIO to Nuance multispectral imaging product family

Hypernetworking and hypertexting bad for kids in more ways than one: Study

ARIAD reports $20.4 million net loss for third quarter 2010

ArQule reduces third quarter net loss to $6,394,000

Semafore's SF1126 for B-cell chronic lymphocytic leukemia granted FDA orphan drug designation

Human blood from adult human skin

Excessive texting and networking raise new health concerns for teens

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in